Danaher Corp. Stock
€168.45
Your prediction

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Danaher
sharewise wants to provide you with the best news and tools for Danaher, so we directly link to the best financial data sources.
Financials
News
Danaher Q2 Earnings Call Highlights
Key Points
- Interested in Danaher Corporation? Here are five stocks we like better.
- Danaher beat Q2 expectations with sales of $6.3 billion, adjusted EPS of $1.94, and $1.3 billion in free cash
Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
Shareholders in biotechnology, life sciences, and diagnostics solutions company Danaher (NYSE: DHR) have had an interesting week. Their stock crashed early in the week on the release of its
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?
Danaher (NYSE: DHR) focuses on life sciences, diagnostics, and industrial solutions for healthcare and sells specialized equipment, software, consumables, and reagents used by pharmaceutical
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline?
Danaher (NYSE: DHR) has been wildly successful for a long time. The stock has returned over 52,700% since its 1969 founding as DMG.
Unfortunately, investors may question, or even forget, the


